Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06122363 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Incomplete Endometrial Ablation

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 12, 2025 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 30, 2023 to Aug 1, 2025
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Dec 30, 2023 to Dec 30, 2025
    • Eligibility criteria revised
    v3
  2. Primary endpoint revised
    • Secondary endpoints revised (4)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the proposed protocol is to study the impact of incomplete endometrial ablation on the PBAC score, reintervention, satisfaction, controlled bleeding and dysmenorrhea at 24 months after Novasure endometrial ablation, in women with heavy menstrual bleeding treated at Máxima Medical Centre Veldhoven, in The Netherlands.
Trial Details
NCT Number NCT06122363
Lead Sponsor Maxima Medical Center
Conditions
(from sponsor)		 Heavy Menstrual Bleeding
Related terms Menorrhagia
Enrollment 121 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov